KYUNG HEE KANG: Open Payments
NPI 1205683380 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 31 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $363 · 2025 $1,052
Food & beverage: $1,052
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $353 |
| Madrigal Pharmaceuticals | 3 | $235 |
| Janssen Biotech, Inc. | 2 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Aimmune Therapeutics, Inc. | 3 | $68 |
| PFIZER INC. | 2 | $45 |
| Intercept Pharmaceuticals, Inc. | 2 | $41 |
| Organon LLC | 2 | $33 |
Products named: REZDIFFRA, TREMFYA, SKYRIZI, RINVOQ, LINZESS, ENTYVIO, VOWST, OCALIVA.
Industry payments across CA — which companies pay providers there.
